FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation

Sep.18.2024
FirstUnion unveiled groundbreaking Alkaid technology at InterTabac, promising revolutionary changes in heat-not-burn smoking experience.

On September 19, at the InterTabac trade fair in Dortmund, Germany, FirstUnion was awarded the 2024 Alternative Awards for "Best HNB Innovation" for its groundbreaking Alkaid Light Heating Technology. This highly prestigious award highlights the revolutionary nature of Alkaid technology in the heated tobacco products (HNB) sector.

 

FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation
Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation | Image source:FirstUnion


That same evening, FirstUnion hosted an exclusive launch event at the world’s premier tobacco industry exhibition, showcasing how Alkaid technology addresses key consumer concerns such as heating speed, flavor quality, device cleanliness, and health impacts.

 

At the heart of Alkaid is its light-heating method, which leverages full-spectrum light waves, mimicking the natural power of sunlight to deliver rapid and uniform heating. Dr. Zhu Bin, FirstUnion's Alkaid light-heating technical lead, highlighted this feat enables the device to preheat in just five seconds, transforming the smoking experience by eliminating long wait times and offering users instant satisfaction with a smooth, seamless draw.

 

FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation
Dr. Zhu Bin, Chief Technology Officer of Alkaid, introduces Alkaid's light heating technology |Image source:FirstUnion

 

FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation
Dr. Zhu Bin, Chief Technology Officer of Alkaid, introduces Alkaid's light heating technology |Image source:FirstUnion

 

Alkaid's rapid heating is only the beginning. The technology delivers superior taste and health benefits that elevate the smoking experience far beyond current standards. Alkaid increases the nicotine release efficiency in aerosols by over 40%,and boosts total particulate matter (TPM) by 20%, delivering an experience that closely mimics traditional cigarettes. Simultaneously, it cuts harmful substance emissions by 20%, significantly reducing potential health risks. Thanks to its innovative non-contact heating design, Alkaid requires no cleaning, ensuring the device maintains consistent, fresh-tasting results even after 5,000 continuous uses.

 

The development of Alkaid technology is the result of four years of extensive research and thousands of experiments conducted by a multidisciplinary team of more than 100 experts in materials science, optics, electronics, and tobacco. Drawing inspiration from solar collectors, Alkaid overcomes the limitations of traditional heating methods by utilizing the speed and penetrating power of light—a revolutionary concept poised to change the future of HNB.

 

FirstUnion has been committed to driving innovation in HNB technology, exploring this field since 2012 and launching several HNB products that have been well-received by the market. The release of Alkaid not only signifies FirstUnion’s continuous leadership at the forefront of the industry but also paves a new path for the global HNB sector.

 

As the tobacco industry moves further toward harm reduction, Alkaid’s unparalleled combination of innovation, practicality, and health benefits places it in prime position to disrupt the market. FirstUnion's commitment to creating better, safer alternatives for consumers is clear, and the introduction of Alkaid marks a bold step forward. As their release theme proudly declares: "Harnessing the power of light to guide the future—Alkaid brings the future within reach."

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02